Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.
O'Reilly D, O'Grady A, Hayes C, Piggott L, Keane R, Fitzpatrick OM, Conroy M, Aretz NK, Synnott D, Dillon R, Dowling GP, Ryan DJ, O'Brien E, Morgan R, Breathnach O, Grogan L, Morris P, Greally M, Teo MY, Murphy A, Ryan G, Counihan I, Ryan C, Barrett H, O'Shea AM, Cuffe S, Korpanty G, Prior L, Barr MP, Finn S, O'Brien C, McCarron S, Cummins R, Toomey S, Dowling CM, Glavey S, Hennessy BT, Sorensen J, Bennett K, Nadarajan P, Doyle B, Naidoo J.
O'Reilly D, et al. Among authors: ryan c.
Eur J Cancer. 2025 Jun 17;225:115582. doi: 10.1016/j.ejca.2025.115582. Online ahead of print.
Eur J Cancer. 2025.
PMID: 40578048